Main Session
Sep
28
SS 15 - Immunotherapy Integration and Immuno Biomarkers Across Mucosal and Cutaneous SCC
176 - Efficacy and Safety of an Adaptive Treatment Strategy for Locoregionally Advanced Nasopharyngeal Carcinoma Based on Response Stratification to Nimotuzumab Plus Induction Chemotherapy: A Prospective Multicenter Phase II Clinical Study
Presenter(s)
Lei Zeng, MD - The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi